Our Press Releases | Association for Accessible Medicines

In the News - View AAM CEO Dan Leonard's blog on the essential role generic drugs play during COVID-19

Happy senior male customer buying medications at drugstore

Apr 29, 2021 | Rachel Schwartz

AAM Statement on The Protecting Access to Affordable Medicines Act

Apr 27, 2021 | Rachel Schwartz

AAM Statement on the Ensuring Access to Lower-Cost Medicines for Seniors Act

Oregon State Capital building

Apr 22, 2021 | Rachel Schwartz

SB 764 Will Hurt Oregon's Most Vulnerable Patients

White Paper: Biosimilars in the U.S.: Reimbursement and Impacts to Uptake

Mar 25, 2021 | Rachel Schwartz

AAM Statement on IQVIA Report Examining Biosimilar Reimbursement and Adoption

Senior patient picking up medicines at a pharmacy

Mar 11, 2021 | Rachel Schwartz

AAM Statement on Avalere Medicare Part D Analysis

American flag in Washington D.C.

Feb 25, 2021 | Rachel Schwartz

AAM Statement on President Biden’s Supply Chain Executive Order

AAM board room

Feb 24, 2021 | Rachel Schwartz

AAM Announces 2021 Board of Directors

AAM Lobby

Feb 24, 2021 | Rachel Schwartz

AAM Announces 2021 Associate Members

Secure Our Meds

Feb 22, 2021 | Rachel Schwartz

AAM Outlines Policy Solutions for Sustained Patient Access to Generic and Biosimilar Medicines

Chiquita Brooks-LaSure

Feb 19, 2021 | Rachel Schwartz

AAM Statement on President Biden’s Nomination of Chiquita Brooks-LaSure as CMS Administrator

Potential Savings from Accelerating US Approval of Complex Generics

Feb 9, 2021 | Rachel Schwartz

Complex Generics Could Save the U.S. Health Care System Approximately $1.3 Billion Per Year

USA flag with generic medicines

Jan 21, 2021 | Rachel Schwartz

AAM Statement on Biden’s Executive Orders to Strengthen America’s COVID Response